Cheyne Capital Management UK LLP acquired a new stake in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 18,927 shares of the company’s stock, valued at approximately $555,000. Cheyne Capital Management UK LLP owned […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) – Stock analysts at Wedbush dropped their Q2 2023 earnings estimates for shares of Aerovate Therapeutics in a note issued to investors on Wednesday, May 17th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings per share of ($0.63) for the quarter, down from their […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) insider Ralph Niven sold 2,250 shares of the stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $20.87, for a total value of $46,957.50. Following the transaction, the insider now owns 1,609 shares in the company, valued at $33,579.83. The […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating)’s stock price rose 10.8% on Thursday . The stock traded as high as $21.03 and last traded at $20.91. Approximately 27,694 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 92,888 shares. The stock had previously closed at $18.88. Wall Street […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) insider Hunter Gillies sold 4,000 shares of the firm’s stock in a transaction on Friday, April 21st. The shares were sold at an average price of $19.50, for a total transaction of $78,000.00. Following the sale, the insider now owns 1,960 shares in the company, valued at $38,220. […]